Medication and lifestyle plan to bring blood sugar to normal
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This Phase 4 study looks at how to help women with a recent history of gestational diabetes get their blood sugar back toward normal levels. It likely includes blood-sugar testing and a controlled diet period to see what works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female, age 18 to 45
- You had gestational diabetes in your most recent pregnancy, and you are 6 months to 10 years postpartum
- Your BMI is 25 or higher (in the overweight range)
- You must not plan pregnancy during the study, and you use reliable birth control (or have had tubal ligation)
- Your blood sugar test shows “prediabetes range” results (impaired fasting or impaired glucose tolerance)
- You can follow study rules like keeping your usual activity level and eating a standardized diet before testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether semaglutide can help women with prediabetes after past gestational diabetes return to better blood sugar levels and lower progression to diabetes. It is designed for women who are no longer breastfeeding and can use effective birth control.
This trial tests a weekly injection (semaglutide) to see if it can help lower the risk of heart disease and type 2 diabetes in women who recently had gestational diabetes. The goal is to improve long-term health after pregnancy.
This study tests a new medication called semaglutide (similar to Ozempic) in people with type 2 diabetes who are already taking metformin. It aims to see if this medication improves blood sugar control and may also help with weight loss.
This trial tests an investigational product to see how well it controls blood sugar in adults with prediabetes or type 2 diabetes. Some participants will also take the diabetes medication semaglutide to compare effects.
This trial tests whether adding a weekly semaglutide injection (a GLP-1 drug) to a closed-loop insulin system can help reduce the need for carb counting in people with type 1 diabetes. It aims to improve blood sugar control and make diabetes management easier.
This trial tests a medication (called a GLP-1 receptor agonist) to see if it can help people in the earliest stage of type 1 diabetes keep their insulin-making cells working longer. It might help delay the need for insulin injections.
Hear when a new Pre Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.